Teleflex Incorporated

255.91+5.34+2.13%Vol 315.26K1Y Perf -34.21%
Aug 8th, 2022 16:04 DELAYED
BID248.76 ASK263.24
Open253.37 Previous Close255.91
Pre-Market- After-Market255.91
 - -  - -%
Target Price
346.92 
Analyst Rating
Moderate Buy 2.25
Potential %
35.56 
Finscreener Ranking
     41.89
Insiders Trans % 3/6/12 mo.
-100/-100/-87 
Value Ranking
★+     43.30
Insiders Value % 3/6/12 mo.
-100/-100/-98 
Growth Ranking
★★★★     59.12
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-98 
Income Ranking
     31.89
Price Range Ratio 52W %
12.23 
Earnings Rating
Neutral
Market Cap12.00B 
Earnings Date
28th Jul 2022
Alpha-0.00 Standard Deviation0.08
Beta1.16 

Today's Price Range

253.01257.31

52W Range

235.01405.90

5 Year PE Ratio Range

22.6088.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.02%
1 Month
0.49%
3 Months
-1.46%
6 Months
-22.95%
1 Year
-34.21%
3 Years
-31.14%
5 Years
21.51%
10 Years
324.41%

TickerPriceChg.Chg.%
TFX255.915.34002.13
AAPL164.87-0.4800-0.29
GOOG118.14-0.0800-0.07
MSFT280.32-2.5900-0.92
XOM88.950.50000.57
WFC43.19-0.5700-1.30
JNJ170.20-0.9100-0.53
FB196.640.99000.51
GE75.180.82001.10
JPM114.35-1.4100-1.22
 
ProfitabilityValueIndustryS&P 500US Markets
55.10
21.90
30.20
13.60
18.97
RevenueValueIndustryS&P 500US Markets
2.10B
44.86
3.58
6.67
DividendsValueIndustryS&P 500US Markets
0.56
1.36
0.00
0.00
Payout ratio23.00
Earnings HistoryEstimateReportedSurprise %
Q02 20223.353.391.19
Q01 20222.732.885.49
Q04 20213.533.601.98
Q03 20213.033.5115.84
Q02 20212.863.3517.13
Q01 20212.442.8717.62
Q04 20203.033.257.26
Q03 20202.272.7722.03
Earnings Per EndEstimateRevision %Trend
6/2022 QR3.35-0.89Negative
9/2022 QR3.59-2.71Negative
12/2022 FY13.94-0.43Negative
12/2023 FY15.26-1.68Negative
Next Report Date-
Estimated EPS Next Report3.35
Estimates Count13
EPS Growth Next 5 Years %10.70
Volume Overview
Volume315.26K
Shares Outstanding46.91K
Shares Float30.41M
Trades Count6.38K
Dollar Volume80.35M
Avg. Volume513.96K
Avg. Weekly Volume574.06K
Avg. Monthly Volume541.50K
Avg. Quarterly Volume426.30K

Teleflex Incorporated (NYSE: TFX) stock closed at 255.91 per share at the end of the most recent trading day (a 2.13% change compared to the prior day closing price) with a volume of 315.26K shares and market capitalization of 12.00B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 14000 people. Teleflex Incorporated CEO is Liam J. Kelly.

The one-year performance of Teleflex Incorporated stock is -34.21%, while year-to-date (YTD) performance is -22.09%. TFX stock has a five-year performance of 21.51%. Its 52-week range is between 235.01 and 405.895, which gives TFX stock a 52-week price range ratio of 12.23%

Teleflex Incorporated currently has a PE ratio of 23.70, a price-to-book (PB) ratio of 3.02, a price-to-sale (PS) ratio of 5.45, a price to cashflow ratio of 19.20, a PEG ratio of 2.32, a ROA of 7.22%, a ROC of 9.15% and a ROE of 13.97%. The company’s profit margin is 18.97%, its EBITDA margin is 30.20%, and its revenue ttm is $2.10 Billion , which makes it $44.86 revenue per share.

Of the last four earnings reports from Teleflex Incorporated, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $3.35 for the next earnings report. Teleflex Incorporated’s next earnings report date is -.

The consensus rating of Wall Street analysts for Teleflex Incorporated is Moderate Buy (2.25), with a target price of $346.92, which is +35.56% compared to the current price. The earnings rating for Teleflex Incorporated stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Teleflex Incorporated has a dividend yield of 0.56% with a dividend per share of $1.36 and a payout ratio of 23.00%.

Teleflex Incorporated has a Sell technical analysis rating based on Technical Indicators (ADX : 7.73, ATR14 : 8.22, CCI20 : -15.97, Chaikin Money Flow : 0.31, MACD : -1.56, Money Flow Index : 48.21, ROC : -2.79, RSI : 39.86, STOCH (14,3) : 44.77, STOCH RSI : 0.40, UO : 54.47, Williams %R : -55.23), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Teleflex Incorporated in the last 12-months were: Andrew A. Krakauer (Buy at a value of $153 732), Cameron P. Hicks (Option Excercise at a value of $435 600), Cameron P. Hicks (Sold 3 600 shares of value $1 260 000 ), Liam J. Kelly (Option Excercise at a value of $2 150 712), Liam J. Kelly (Sold 35 948 shares of value $12 695 366 ), Stuart A. Randle (Option Excercise at a value of $236 599), Stuart A. Randle (Sold 3 014 shares of value $853 896 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (25.00 %)
4 (33.33 %)
4 (36.36 %)
Moderate Buy
3 (25.00 %)
3 (25.00 %)
3 (27.27 %)
Hold
6 (50.00 %)
5 (41.67 %)
4 (36.36 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.25
Moderate Buy
2.08
Moderate Buy
2.00

Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (26% of 2020 sales), interventional (15%), surgical (13%), anesthesia (12%), interventional urology (13%), original-equipment manufacturing (7%), and all other (14%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

CEO: Liam J. Kelly

Telephone: +1 610 225-6800

Address: 550 East Swedesford Road, Wayne 19087, PA, US

Number of employees: 14 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

66%34%

Bearish Bullish

61%39%

TipRanks News for TFX

Mon, 01 Aug 2022 12:36 GMT Analysts Offer Insights on Healthcare Companies: Laboratory (LH), Teleflex (TFX) and Amedisys (AMED)

- TipRanks. All rights reserved.

Fri, 15 Jul 2022 20:36 GMT Teleflex (TFX) Gets a Hold Rating from Morgan Stanley

- TipRanks. All rights reserved.

Mon, 23 May 2022 12:55 GMT Teleflex (TFX) Gets a Buy Rating from Needham

- TipRanks. All rights reserved.

Mon, 23 May 2022 12:35 GMT Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Intra-Cellular Therapies (ITCI) and Chinook Therapeutics (KDNY)

- TipRanks. All rights reserved.

Mon, 17 Jan 2022 06:04 GMT Teleflex (TFX) Receives a Buy from RBC Capital

- TipRanks. All rights reserved.

News

Stocktwits